CXL Ophthalmics Overview

  • Founded
  • 2012
  • Status
  • Private

CXL Ophthalmics General Information


Provider of medical devices designed to develop an innovative treatment for keratoconus and other corneal ectasias. The company's devices help to overcome the weakened cornea, the tough, clear, outer surface of the eye's pupil that weakened cornea progressively changing its shape and degrades vision, the proteins that make up the cornea can be strengthened by chemically cross-linking them, enabling patients to avail of enhanced vision that is available in wide range for the treatment of eye diseases

Contact Information

Ownership Status
Privately Held (no backing)
Financing Status
Primary Industry
Surgical Devices
Primary Office
  • 4354 Manchester Avenue
  • Encinitas, CA 92024
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CXL Ophthalmics Executive Team (5)

Name Title Board Seat Contact Info
Michael Webb President & Chief Executive Officer
Roy S. Rubinfeld MD Founder & Chief Scientific Officer
Alan Russell Ph.D Chief Development & Regulatory Officer
Michael W. Belin MD Chief Medical Officer
You’re viewing 4 of 5 executive team members. Get the full list »

CXL Ophthalmics Board Members (2)

Name Representing Role Since
Jonathan Talamo MD Self Senior Medical Advisor & Board Member 000 0000
Marc Odrich MD CXL Ophthalmics Senior Medical Advisor & Board Member 000 0000
To view CXL Ophthalmics’s complete board members history, request access »